PHARMACY

QuintilesIMS rebrands as IQVIA

BY David Salazar

DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — Analytics company QuintilesIMS has a new name. Effective Nov. 6, the company will do business as IQVIA, with its name ticker symbol on the New York Stock Exchange set to switch to IQV on Nov. 15. The name change comes almost a year and a half after Quintiles merged with IMS Health in a $9 billion deal.

“Today is a defining moment for our organization as we introduce a new name that aligns with our vision to help stakeholders drive healthcare forward,” IQVIA Chairman and CEO Ari Bousbib said. “Our clients have been instrumental in our becoming IQVIA. IMS Health and Quintiles came together because our clients were asking for better, faster ways to bring innovations to patients and capture the improvements the industry has been pursuing for years.”

IQVIA also announced that its client solutions would be powered by the IQVIA CORE, which it says allows the company to offer customized solutions for its clients using advanced analytics and extensive industry knowledge.

“Since the merger, we’ve worked to integrate our capabilities in advanced analytics, leading technologies and therapeutic expertise into powerful, differentiated offerings,” Bousbib said. “Our vision is to outpace the inevitable progress of change across the life sciences and accelerate our ability to empower healthcare decision makers to meet the future head on.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Mylan intros generic Clolar for injection

BY David Salazar

PITTSBURGH — Mylan has introduced its generic of Clolar (clofarabine 1 mg/ml) injection. The drug is indicated to treat patients ages 1 year to 21 years with relapsed or refractory acute lymphoblastic leukemia after at least two prior treatment regimens.

The latest launch adds to Mylan’s oncology portfolio, which it said contains more than 40 products. Mylan’s Clolar generic will be available in single-dose vials.

According to data from IQVIA (formerly QuintilesIMS), the drug had U.S. sales of $53 million for the 12 months ended Sept. 30.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

CVS Health offers diabetes management support for American Diabetes Month

BY David Salazar

WOONSOCKET, R.I. — CVS Health is marking American Diabetes Month by emphasizing efforts patients can undertake to manage their conditions, as well as the services the company offers to make diabetes management easier.

The company said patients with diabetes should manage their diet and engage in a healthy lifestyle — including at least 30 minutes of exercise daily — in an effort to manage their blood glucose, blood pressure and cholesterol. CVS pharmacists also can offer information and product suggestions to aid lifestyle management, CVS Health said.

Beyond the pharmacy, the company has launched several efforts aimed at boosting adherence through its CVS Caremark pharmacy benefits managers. The recently launched ReducedRx program offers discounts on such drugs as insulin to improve patient adherence, its Transform Diabetes Care program offers its POBM clients tools to help manage their conditions. Transform Diabetes Care includes a connected glucometer that can store blood glucose readings in the cloud and integrate them into an electronic health record.

The company also noted that its MinuteClinic locations offer A1C checks.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?